Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up-Reference-Cited by-同舟云学术

Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up

Published:2022-04 Issue:4 Volume:24 Page:421-427
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wu Zhixian,Xu Xiumin,Cai Jinquan,Chen Jin^ORCID,Huang Lianghu,Wu Weizhen,Pugliese Alberto,Li Shasha,Ricordi Camillo,Tan Jianming

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference27 articles.

1. Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man;Skyler;Diabetes,2011

2. The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study;Zgibor;Diabetes Care,2000

3. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion;Cai;Diabetes Care,2016

4. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus;Thakkar;Cytotherapy,2015

5. Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations;Snarski;Bone Marrow Transplant,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting neuroinflammation in distal symmetrical polyneuropathy in diabetes;Drug Discovery Today;2024-08

2. Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy;Biomedicine & Pharmacotherapy;2024-06

3. Downregulation of hsa-miR-100-5p May Be a Protective Factor in the Early Stages of Nephropathy in Type 1 Diabetes Mellitus;International Journal of Molecular Sciences;2024-05-23

4. Cell Therapies and Gene Therapy for Diabetes: Current Progress;Current Diabetes Reviews;2024-05-13

5. Efficacy of mesenchymal stromal cells in the treatment of type 1 diabetes: a systematic review;Cell and Tissue Banking;2024-02-21